about
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritisNucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.Mass spectrometric and peptide chip epitope mapping of rheumatoid arthritis autoantigen RA33.Proteome analysis of diseased joints from mice suffering from collagen-induced arthritis.The ancient mammalian KRAB zinc finger gene cluster on human chromosome 8q24.3 illustrates principles of C2H2 zinc finger evolution associated with unique expression profiles in human tissues.Mass spectrometric and peptide chip epitope analysis on the RA33 autoantigen with sera from rheumatoid arthritis patients.EJMS protocol: systematic studies on TiO2-based phosphopeptide enrichment procedures upon in-solution and in-gel digestions of proteins. Are there readily applicable protocols suitable for matrix-assisted laser desorption/ionization mass spectrometrA novel strategy for the rapid preparation and isolation of intact immune complexes from peptide mixtures.Ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for phosphopeptide analysis with a solidified ionic liquid matrix.A computational method for designing diverse linear epitopes including citrullinated peptides with desired binding affinities to intravenous immunoglobulin.High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.Recombinant human casein kinase II. A study with the complete set of subunits (alpha, alpha' and beta), site-directed autophosphorylation mutants and a bicistronically expressed holoenzyme.Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells.The B-subdomain of the Xenopus laevis XFIN KRAB-AB domain is responsible for its weaker transcriptional repressor activity compared to human ZNF10/Kox1.Casein kinase II is required for transition of G0/G1, early G1, and G1/S phases of the cell cycle.System for quantitation of gene expression in single cells by computerized microimaging: application to c-fos expression after microinjection of anti-casein kinase II antibody.Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome.Probing the epitope signatures of IgG antibodies in human serum from patients with autoimmune disease.A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same geneCell biological studies with monoclonal and polyclonal antibodies against human casein kinase II subunit beta demonstrate participation of the kinase in mitogenic signalingInteraction sites between catalytic and regulatory subunits in human protein kinase CK2 holoenzymes as indicated by chemical cross-linking and immunological investigationsRequirement of casein kinase 2 for entry into and progression through early phases of the cell cycleFrom transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodiesCongenital heart block associated with a maternal anti-HsEg5-like autoantibodyIdentification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigenMS characterization of apheresis samples from rheumatoid arthritis patients for the improvement of immunoadsorption therapy - a pilot studyDUF3669, a "domain of unknown function" within ZNF746 and ZNF777, oligomerizes and contributes to transcriptional repression
P50
Q24797400-22ECCB59-6591-43DA-AAB3-2828E95F401FQ30453773-9AE5EF05-5EC3-42A9-A3AA-1177FE1D2284Q30919668-64B8FF8B-C937-4095-9127-824224B3EA1DQ33196541-BC19ECAE-319F-4A28-B25E-027E7DA5DD8FQ33546685-F7E20988-DCA5-4036-A062-F35ACC0FB311Q33597491-EB78442C-466F-4710-98C4-B800336A0C24Q34102425-A45014E4-4AE1-4870-AE99-9976E130FEC1Q35209717-8B4E158A-9B1E-415B-BB48-92197DE83E69Q35693367-FB990769-D007-459C-9239-E0E10DBC94D9Q35984163-65FF3E3B-350A-4179-A930-0EFA03375770Q36778303-45B0A04F-B1FC-4037-AD71-46DD558F21BDQ38311064-6CC14CDD-9090-4DC3-A7A9-F0D337804F95Q38351135-B51CF03A-471B-4EB6-AE9D-CFD01E1A036CQ39026954-DBE21EFC-DD7B-45F1-BFF0-043C4FF3019AQ41481492-568EB513-4C65-45E7-931A-6924A15F0F68Q41575194-6BF165B0-8716-41E0-9FE2-8E551FDF7F1EQ43835851-E0A94323-E649-42CB-952C-4DED10D2FA96Q44760573-B7876D6C-0343-4ACE-98FE-31C5D2DAD67FQ64261464-60F4B872-3822-4769-ABBB-87F585934593Q70550525-4A96AA65-1C45-484B-BC90-0D69B083AB37Q71145601-ECAFA7CE-6687-4DC3-92AE-C657B0C2FFF0Q72204254-B627B953-81C6-4DD4-8505-33D60DC1BF17Q73589775-A10F4CE6-F105-435B-91CE-5A59AD61A674Q81369267-F6D523EA-C39B-408F-8414-C30F34BD2D08Q82216433-5FA5D693-94A3-471C-AE89-9C8E99569502Q82776380-25E0819C-13AF-489C-ACDC-37B4B172E6CCQ92127711-B13D6CFA-2B4F-4DEA-9460-3FAE99A52F90
P50
description
researcher
@en
wetenschapper
@nl
name
Lorenz P
@nl
Peter A. Lorenz
@en
type
label
Lorenz P
@nl
Peter A. Lorenz
@en
altLabel
Lorenz P
@en
prefLabel
Lorenz P
@nl
Peter A. Lorenz
@en
P106
P31
P496
0000-0001-7925-1002